News

Brintellix was discovered by Lundbeck researchers and the clinical trial program in the US was conducted jointly by the two firms, while Takeda holds the NDA for the

"Immuno-oncology has emerged as a particularly promising field to create potentially curative treatment options for many cancer patients," said Victoria Richon, Vice-President and Head of Cancer Research, Discovery

Both the firms will collaborate on seeking regulatory approval from Australia’s Therapeutic Goods Administration (TGA) and New Zealand’s Medicines and Medical Devices Safety Authority (Medsafe). As part of

Manapol is a pure, premium, 100 percent aloe vera gel extract, designed to support cell-to-cell communication.* Mannatech’s offering has a guaranteed molecular weight of more than one million

Under the deal, DKSH will be responsible for providing regulatory, distribution and logistics services for Actelion in Hong Kong, Malaysia and Singapore. Initially, the deal covers Tracleer, a

"Every year, millions of women transition into menopause causing them to experience a variety of symptoms," stated Gale Bensussen, CEO, Doctor’s Best. "We know they prefer not to

LJPC-401 is being evaluated in a Phase I clinical trial and the company intends to release preliminary results from this trial by the end of this year. Hepcidin

The company’s ANDA product is a generic version of Merck’s Noxafil which is an antifungal agent indicated to treat prophylaxis of invasive Aspergillus and Candida infections. Noxafil is

Bortezomib, which will be marketed under the brand name Vortemyel, is the first therapeutic proteasome inhibitor anticancer drug, used to treat multiple myeloma and mantle cell lymphoma. Following